| Market Cap | ₹18,639Cr |
| ROE | 2.34% |
| P/E Ratio(TTM) | 466.17 |
| EPS(TTM) | 3.49 |
| P/B Ratio | 3.16 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.36 |
| Book Value | 515.40 |
| Debt to Equity | 0.22 |
| Face Value | 1 |
| Parent Organisation | Onesource Specialty Pharma |
| NSE Symbol | ONESOURCE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 70.20 | ||
| Anthem Biosciences | NA (0.00%) | 70.98 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 23.00 | ||
| Panacea Biotec | NA (0.00%) | -285.08 |